VODG Financials 07/15/2014 19:10:17 Vitro Diagnos

VODG Financials 07/15/2014 19:10:17
Vitro Diagnostics, Inc.
Period Ending Oct 31, 2013 Oct 31, 2012 Oct 31, 2011 Oct 31, 2010
Total Revenue 35 28 23 16
Cost of Revenue 15 13 9 7
Gross Profit 20 15 14 8
Operating Expenses
Research and Development 120 126 138 178
Sales, General and Admin. 51 68 78 92
Non-Recurring Items - - - -
Other - - - -
Operating Income (151) (179) (202) (261)
Income From Continuing Operations
Add'l Income/Expense Items - - 229 46
Earnings Before Interest and Tax (151) (179) 27 (216)
Interest Expense 60 49 41 42
Earnings Before Tax (211) (228) (14) (257)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (211) (228) 176 (257)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (211) (228) (14) (257)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (211) (228) (14) (257)